Pazzagli, Laura http://orcid.org/0000-0002-1908-6073
Liang, David
Andersen, Morten
Linder, Marie
Khan, Abdul Rauf
Sessa, Maurizio
Funding for this research was provided by:
Novo Nordisk Foundation (NNF15SA0018404, NNF15SA0018404)
Karolinska Institute
Article History
Received: 25 October 2021
Accepted: 25 March 2022
First Online: 15 April 2022
Competing interests
: Dr. Pazzagli and Dr. Linder are employees at the Centre for Pharmacoepidemiology, which receives grants from several entities (pharmaceutical companies, regulatory authorities, and contract research organizations) for the performance of drug safety and drug utilization studies, unrelated to this work. Mr. Liang discloses that the opinions expressed in this manuscript are solely his own and do not express the views or opinion of Ferring Pharmaceuticals. The other authors declare no competing interests.